Showing results (631-640 of 919) with videos related to

Sort By:
Pageof 92
Pharmaceutics|August 28, 2025
Latest Advances in Inhalable Dry Powder Bacteriophage Therapy for Pulmonary InfectionsDavid Encinas-Basurto, Patricia Dolores Martinez-Flores, Joselyn García, et al.
Optics Letters|April 15, 2020
Mode-selective few-mode Brillouin fiber lasers based on intramodal and intermodal SBSNing Wang, J C Alvarado-Zacarias, Md Selim Habib, et al.
Optics Letters|July 1, 2021
Photonic lantern tip/tilt detector for adaptive optics systemsDaniel Cruz-Delgado, Juan Carlos Alvarado-Zacarias, Matthew A Cooper, et al.
The American Journal of Surgical Pathology|September 22, 2023
International Society of Urological Pathology (ISUP) Consensus Conference on Current Issues in Bladder Cancer: Working Group 3: Subcategorization of T1 Bladder CancerAntonio Lopez-Beltran, Maria R Raspollini, Donna Hansel, et al.
Virchows Archiv : an International Journal of Pathology|January 18, 2020
Clinicopathologic analysis of upper urinary tract carcinoma with variant histologyInês Rolim, Vanessa Henriques, Nídia Rolim, et al.
Optics Express|January 16, 2019
Transverse mode-switchable fiber laser based on a photonic lanternNing Wang, J C Alvarado Zacarias, J Enrique Antonio-Lopez, et al.
Molecular Oncology|August 9, 2014
Selective activity over a constitutively active RET-variant of the oral multikinase inhibitor dovitinib: results of the CNIO-BR002 phase I-trialMiguel Quintela-Fandino, Maria J Bueno, Luis Lombardia, et al.
Seminars in Cancer Biology|October 17, 2017
Genito-urinary genomics and emerging biomarkers for immunomodulatory cancer treatmentThomas Gevaert, Rodolfo Montironi, Antonio Lopez-Beltran, et al.
World Journal of Urology|August 3, 2018
Update of the International Consultation on Urological Diseases on bladder cancer 2018: non-urothelial cancers of the urinary bladderShaheen Alanee, Isabel Alvarado-Cabrero, Paari Murugan, et al.
Cancers|June 10, 2023
Texture Analysis of the Apparent Diffusion Coefficient Focused on Contrast-Enhancing Lesions in Predicting Survival for Bevacizumab-Treated Patients with Recurrent GlioblastomaAntonio Lopez-Rueda, Josep Puig, Santiago Thió-Henestrosa, et al.
Pageof 92